COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19.
Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19. Med Hypotheses. 2021 01; 146:110380.
View in:
PubMed
subject areas
Cell Cycle
Cell Division
Cyclin-Dependent Kinases
Humans
Protein Kinase Inhibitors
Virus Replication
authors with profiles
Anis Abobaker
Aboubaker Alzwi
Mohamed Gargouri